Tag Archives: Eli

Pharm Exec Podcast Series:
Bill Trombetta Industry Audit (Part 2)

[display_podcast] Continuing Pharm Exec editor Patrick Clinton’s conversation with Bill Trombetta on the top four pharma companies and what makes them special. Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly’s position as a big/small […]
Posted in R&D, Safety, Strategy | Also tagged , , | Leave a comment
  • Categories

  • Meta